An understanding of connections between gut microbiome and liver has provided important
insights into the pathophysiology of liver diseases. Since gut microbial dysbiosis increases …

In many countries worldwide, the burden of hepatocellular carcinoma (HCC) associated with
non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is …

Nonalcoholic fatty liver disease (NAFLD) is leading chronic liver syndrome worldwide. Gut
microbiota dysbiosis significantly contributes to the pathogenesis and severity of NAFLD …

Methods The gut microbiome was analyzed via next-generation sequencing in healthy
people (n= 37) and NAFLD patients with elevated liver enzymes (n= 57). Six-week-old male …

Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease in most
parts of the world affecting one-third of the western population and a growing cause for end …

Abstract The Human Microbiome Initiative of NIH, begun in 2007, has opened the door to the
power of the intestinal microbiome in health and disease. The 100 trillion gut microbes …

Gut microbiota is a complex ecosystem seen as an extension of human genome. It
represents a major metabolic interface of interaction with food components and xenobiotics …

Abstract Background/Objectives Non-alcoholic fatty liver disease (NAFLD) causes a wide
spectrum of liver damage, from simple steatosis (SS) to cirrhosis. SS and non-alcoholic …

Objectives Non-alcoholic fatty liver disease (NAFLD) has a growing epidemiologic and
economic burden. It is associated with Western diet (WD) patterns, and its pathogenesis …

Background Our previous studies found that Pure total flavnoids from citrus (PTFC) can
effectively improve non-alcoholic steatohepatitis (NASH) in mice. Here, we discuss on the …